Form 8-K - Current report:
SEC Accession No. 0001193125-19-045422
Filing Date
2019-02-20
Accepted
2019-02-20 16:30:34
Documents
10
Period of Report
2019-02-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d695922d8k.htm 8-K 36753
2 EX-4.1 d695922dex41.htm EX-4.1 617761
3 EX-99.1 d695922dex991.htm EX-99.1 8455
4 GRAPHIC g695922g0219033311077.jpg GRAPHIC 4684
5 GRAPHIC g695922st47.jpg GRAPHIC 2929
6 GRAPHIC g695922st48.jpg GRAPHIC 3579
7 GRAPHIC g695922st49.jpg GRAPHIC 3551
8 GRAPHIC g695922st50.jpg GRAPHIC 3440
9 GRAPHIC g695922st51.jpg GRAPHIC 3166
10 GRAPHIC g695922st52.jpg GRAPHIC 5818
  Complete submission text file 0001193125-19-045422.txt   702907
Mailing Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121
Business Address 6769 MESA RIDGE RD. SAN DIEGO CA 92121 8584103134
INOVIO PHARMACEUTICALS, INC. (Filer) CIK: 0001055726 (see all company filings)

EIN.: 330969592 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14888 | Film No.: 19618692
SIC: 3841 Surgical & Medical Instruments & Apparatus